Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Med Virol ; 95(10): e29168, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37815403

RESUMO

Ocular manifestations have been well recognized in coronavirus disease 2019 (COVID-19) outbreak. Several studies have detected ocular manifestations in patients after COVID-19. However, little is known about the retinal and vitreal alterations in patients before and after COVID-19 infection. This study aimed to investigate the retinal and vitreal alterations in patients before and after contracting COVID-19 infection using swept-source optical coherence tomography (SS-OCT) and angiography (SS-OCTA). A total of 38 participants (76 eyes) were enrolled and followed-up 1 month after COVID-19 infection. Then, 26 patients (52 eyes) were evaluated 3 months after COVID-19 infection. Compared with the pre-COVID-19 status, patients with 1- and 3-month post-COVID-19 statuses had significant thinning of ganglion cell and inner plexiform layer, thickening of inner nuclear layer, a decrease in the vessel density (VD) of superficial vascular complex, and an increase in the VD of deep vascular complex. Meanwhile, alteration in parameters of foveal avascular zone (all p < 0.05) and hyper-reflective dots in the vitreous of 27 patients (54 eyes) (71.1% vs. pre-COVID-19, 34.2%, p = 0.006) were observed. These findings suggest significantly retinal and vitreal alterations occurred in patients after COVID-19 infection, possibly due to direct or indirect virus-induced injuries. Further longitudinal studies are required to investigate the long-term effects of COVID-19 infection on the human eyes.


Assuntos
COVID-19 , Vasos Retinianos , Humanos , Vasos Retinianos/diagnóstico por imagem , Tomografia de Coerência Óptica/métodos , Angiofluoresceinografia/métodos , COVID-19/diagnóstico por imagem , Retina/diagnóstico por imagem
3.
J Neuroophthalmol ; 2023 Aug 25.
Artigo em Inglês | MEDLINE | ID: mdl-37624772

RESUMO

BACKGROUND: For patients with multiple sclerosis (MS), both structure and microvasculature alterations in the inner retina have been investigated in several studies. However, little is known about the alterations in the outer retina and choroid. Hence, this study aimed to assess the outer retinal and choroidal changes in patients with MS with no history of optic neuritis (ON). METHODS: Patients with MS and healthy control participants were enrolled in this cross-sectional study. Quantitative analyses were performed using swept source optical coherence tomography and swept source optical coherence tomography angiography images to assess outer retina thickness (ORT) and choroid thickness (CT), vessel density (VD) of choriocapillaris, and choroidal vascularity index (CVI), which were then compared between the groups. RESULTS: A total of 37 participants with MS (72 eyes) and 74 healthy control participants (148 eyes) were included in this study. Compared with healthy controls, patients with MS with no history of ON showed reduced VD of the choriocapillaris and CVI. There was no significant difference in ORT and CT between 2 groups. Meanwhile, in patients with MS, no correlation between OCTA parameters and expanded disability status scale score were found in this study. CONCLUSIONS: Our study indicates that patients with MS with no history of optical neuritis have reduced choriocapillaris vessel density and decreased choroidal vascularity index without detectable alteration in outer retina thickness and choroid thickness. The findings complement the outer retinal and choroidal component of MS, providing deeper insight into the pathophysiology of MS.

4.
Biochim Biophys Acta Gene Regul Mech ; 1866(3): 194964, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37536559

RESUMO

Retinoblastoma (RB) is a common malignancy that primarily affects pediatric populations. Although a well-known cause of RB is RB1 mutation, MYCN amplification can also lead to the disease, which is a poor prognosis factor. Studies conducted in various tumor types have shown that MYCN inhibition is an effective approach to impede tumor growth. Various indirect approaches have been developed to overcome the difficulty of directly targeting MYCN, such as modulating the super enhancer (SE) upstream of MYCN. The drug used in this study to treat MYCN-amplified RB was THZ1, a CDK7 inhibitor that can effectively suppress transcription by interfering with the activity of SEs. The study findings confirmed the anticancer activity of THZ1 against RB in both in vitro and in vivo experiments. Therapy with THZ1 was found to affect numerous genes in RB according to the RNA-seq analysis. Moreover, the gene expression changes induced by THZ1 treatment were enriched in ribosome, endocytosis, cell cycle, apoptosis, etc. Furthermore, the combined analysis of ChIP-Seq and RNA-seq data suggested a potential role of SEs in regulating the expression of critical transcription factors, such as MYCN, OTX2, and SOX4. Moreover, ChIP-qPCR experiments were conducted to confirm the interaction between MYCN and SEs. In conclusion, THZ1 caused substantial changes in gene transcription in RB, resulting in inhibited cell proliferation, interference with the cell cycle, and increased apoptosis. The efficacy of THZ1 is positively correlated with the degree of MYCN amplification and is likely exerted by interfering with MYCN upstream SEs.


Assuntos
Neoplasias da Retina , Retinoblastoma , Criança , Humanos , Proteína Proto-Oncogênica N-Myc/genética , Retinoblastoma/tratamento farmacológico , Retinoblastoma/genética , Quinase Ativadora de Quinase Dependente de Ciclina , Quinases Ciclina-Dependentes/genética , Fatores de Transcrição SOXC
6.
J Alzheimers Dis ; 92(4): 1451-1458, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36911941

RESUMO

BACKGROUND: The relationship between cataracts and Alzheimer's disease (AD) has been reported in recent observational studies. However, it is still unclear whether a causal effect of cataracts on AD or reverse causation exists. OBJECTIVE: To explore the association between cataracts and AD genetically, we performed a bidirectional two-sample Mendelian randomization study. METHODS: We obtained genetic instrumental variables related to cataracts and AD from recently published genome-wide association studies (GWASs). SNP-outcome associations for AD were obtained from a GWAS with 111,326 cases and 677,663 controls. SNP-outcome associations for cataracts were drawn from two sources: a GWAS with 67,844 cases and 517,399 controls and the FinnGen consortium (42,843 cases and 262,698 controls). Inverse variance weighted (IVW) was used as the primary method for Mendelian randomization (MR) analyses. RESULTS: No genetic evidence suggested that cataracts were associated with the risk of AD (IVW odds ratio =1.04, 95% confidence interval: 0.98-1.10, p=0.199). In contrast, an effect of genetically determined AD on a decreased risk of cataract was observed with suggestive evidence (IVW odds ratio =0.96, 95% confidence interval: 0.93-0.99, p=0.004). However, this result might be distorted by survival bias. CONCLUSION: Genetically determined cataracts were not related to AD, as demonstrated by our study. In contrast, there was suggestive evidence that AD might prevent cataract development, but there might be potential survival bias. To define the exact association between the two diseases, more prospective research and studies on the pathogenesis are needed.


Assuntos
Doença de Alzheimer , Catarata , Humanos , Doença de Alzheimer/epidemiologia , Doença de Alzheimer/genética , Estudo de Associação Genômica Ampla , Análise da Randomização Mendeliana , Estudos Prospectivos , Catarata/epidemiologia , Catarata/genética , Polimorfismo de Nucleotídeo Único/genética
7.
World J Surg Oncol ; 20(1): 140, 2022 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-35490241

RESUMO

BACKGROUND: Pulmonary sclerosing pneumocytoma is a kind of rare benign pulmonary tumor with potential malignancy. The clinical features, risk factors for prognosis, and optimal treatment have not been identified yet. This study aimed to investigate the clinical features and prognosis of pulmonary sclerosing pneumocytoma. METHODS: We retrospectively performed a review of pulmonary sclerosing pneumocytoma patients in West China Hospital from 2009 to 2019. The basic characteristics, treatment regimens, operation detail, postoperative variables, and follow-up time were recorded for each case. Differences in features between patients undergoing lobectomy and segmentectomy were compared. We also performed a case review and summarized reported clinical features in former studies. RESULTS: Altogether 61 pulmonary sclerosing pneumocytoma patients were retrospectively reviewed. Fifty-six patients were female and 5 were male. The patients' median age was 51 (23-73). Seven (11.48%) patients had smoking history. Twenty tumors were located in the right lung [upper lobe (n = 7), middle (n = 2), and lower (n = 11)] and 41 in the left [upper (n = 12) and lower (n = 29)]. The median tumor size was 2 (0.9-7) cm. Thirty-six (59.02%) patients underwent sublobectomy (segmentectomy or wedge resection) whereas 25 (40.98%) underwent lobectomy. All patients recovered uneventfully, and no perioperative mortality was identified. Sublobectomy showed a trend towards reduced chest tube duration and shorter postoperative hospital stays compared with lobectomy. CONCLUSIONS: The findings showed good prognosis of pulmonary sclerosing pneumocytoma and proved its benign characteristics. Sublobectomy showed advanced efficacy regarding chest tube duration and postoperative hospital stay compared with lobectomy.


Assuntos
Neoplasias Pulmonares , Hemangioma Esclerosante Pulmonar , Feminino , Humanos , Pulmão/patologia , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/cirurgia , Masculino , Pessoa de Meia-Idade , Prognóstico , Hemangioma Esclerosante Pulmonar/patologia , Hemangioma Esclerosante Pulmonar/cirurgia , Estudos Retrospectivos
8.
Curr Eye Res ; 46(12): 1886-1891, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34348531

RESUMO

Background: Parkinson's Disease (PD) is the second-most common neurodegenerative disease affecting the elderly population. The eye has been referred to as a window to the brain due to its inseparable relationship with the central nervous system. The development of Swept-Source Optical Coherence Tomography (SS-OCT) and Optical Coherence Tomography Angiography (OCTA) technologies has offered us a better imaging modality to study the impact of PD on the retina.Method: Seventy-five eyes of 42 early-stage PD patients and 150 eyes of 75 matched healthy controls were enrolled in the current study. We performed SS-OCT and SS-OCTA to assess retinal nerve fiber layer (RNFL), ganglion cell layer (GCL) + inner plexiform layer (IPL), internal nuclear layer (INL) thickness, and retinal flow density and flow ratio.Results: Our study indicates decreasing superficial and deep flow density in most regions of the retina. Superficial and deep flow parameters were also associated with RNFL, GCL+IPL, and INL thickness. ROC analysis reveals superficial flow density demonstrated an Area Under Curve (AUC) of 0.688, which is greater than deep flow density and retinal thickness measurements.Conclusion: To the best of our knowledge, we are the first study using SS-OCT and SS-OCTA to study superficial and deep retinal flow changes in early-stage PD patients. Our study suggests decreasing retinal flow density provides greater diagnostic power than retinal thickness measurements in the early stage of PD. SS-OCTA parameters could potentially serve as imaging biomarkers in PD diagnosis and staging.


Assuntos
Angiofluoresceinografia/métodos , Doença de Parkinson/diagnóstico , Fluxo Sanguíneo Regional/fisiologia , Retina/fisiopatologia , Vasos Retinianos/fisiopatologia , Tomografia de Coerência Óptica/métodos , Feminino , Fundo de Olho , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/fisiopatologia , Curva ROC , Retina/diagnóstico por imagem , Vasos Retinianos/diagnóstico por imagem
9.
Trials ; 21(1): 232, 2020 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-32106877

RESUMO

BACKGROUND: Pleural lavage is regularly performed before closing the chest wall in pulmonary surgeries to prevent pleural implantation of tumor cells and postoperative infection. However, scant data could be found in the literature regarding the optimal regimen for performing pleural lavage. To establish a proper volume of pleural lavage, we herein designed a protocol for a randomized controlled trial. METHODS: A total of 400 participants with non-small cell lung cancer undergoing video-assisted thoracoscopic surgery (VATS) lobectomy and systematic mediastinal lymph node dissection (MLND) will be randomly assigned to one of two groups: group A (500 mL pleural lavage fluid) and group B (3000 mL pleural lavage fluid). The primary outcomes include the levels of leukocytes, neutrophils, and inflammatory factors on the first postoperative day. The secondary outcomes include (i) the levels of leukocytes, neutrophils, and inflammatory factors on the second and third postoperative days; (ii) the incidence of postoperative fever on the first, second, and third postoperative days; (iii) the volumes of chest drainage within the first 3 operative days, the duration of drainage, and postoperative hospitalization; and (iv) the incidence of postoperative complications (incision infection, pain, atelectasis, hemorrhage, etc.) and the incidence of pleural effusion requiring thoracic puncture or drainage within 30 days after surgery. The main content of the analysis includes effectiveness and safety analysis. We will perform subgroup analyses to identify potential influence factors. DISCUSSION: As far as we know, this will be the first randomized controlled trial to compare the clinical outcomes between different volumes of pleural lavage fluid following VATS and MLND. Findings from this trial will determine the appropriate amount of pleural lavage before chest wall closure. TRIAL REGISTRATION: This study was registered with the Chinese Clinical Trial Registry ( on 17 March 2019. ChiCTR 1900021950).


Assuntos
Carcinoma Pulmonar de Células não Pequenas/cirurgia , Neoplasias Pulmonares/cirurgia , Excisão de Linfonodo , Pneumonectomia/métodos , Irrigação Terapêutica/métodos , Cirurgia Torácica Vídeoassistida , Carcinoma Pulmonar de Células não Pequenas/patologia , Tubos Torácicos , Drenagem , Humanos , Neoplasias Pulmonares/patologia , Excisão de Linfonodo/efeitos adversos , Pleura/cirurgia , Pneumonectomia/efeitos adversos , Complicações Pós-Operatórias/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Risco , Método Simples-Cego , Cirurgia Torácica Vídeoassistida/efeitos adversos , Fatores de Tempo , Resultado do Tratamento
10.
Transplantation ; 103(12): 2624-2633, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31369516

RESUMO

BACKGROUND: Lung transplantations (LTx) have become an effective lifesaving treatment for patients with end-stage lung diseases. While the shortage of lung donor pool and severe posttransplantation complications exaggerate the obstacle of LTx. This meta-analysis aimed to evaluate the efficacy of donation after circulatory death (DCD) in LTx for patients with end-stage lung diseases. METHODS: PubMed, EmBase, and Web of Science were systematically searched for all relevant studies comparing the efficacy of DCD and conventional donation after brain death (DBD). The relative risk (RR) value as well as the weighted mean difference with a 95% confidence interval (CI) were pooled for dichotomous and continuous outcomes, respectively. The heterogeneity across the included studies was also assessed carefully. RESULTS: Overall, 17 studies with 995 DCD recipients and 38 579 DBD recipients were included. The pooled analysis showed comparable 1-year overall survival between the 2 cohorts (RR 0.89, 95% CI, 0.74-1.07, P = 0.536, I = 0%). The airway anastomotic complications rate in DCD cohort was higher than that in DBD cohorts (RR 2.00; 95% CI, 1.29-3.11, P = 0.002, I = 0%). There was no significant difference between DCD and DBD regarding the occurrence of primary graft dysfunction grade 2/3, bronchiolitis obliterans syndrome, acute transplantation rejection, and length of stay. The stability of the included studies was strong. CONCLUSIONS: Evidence of this meta-analysis indicated that the use of lungs from DCD donors could effectively and safely expand the donor pool and therefore alleviate the crisis of organ shortage.


Assuntos
Transplante de Pulmão/mortalidade , Insuficiência Respiratória/cirurgia , Doadores de Tecidos/provisão & distribuição , Obtenção de Tecidos e Órgãos/métodos , Saúde Global , Sobrevivência de Enxerto , Humanos , Insuficiência Respiratória/mortalidade , Taxa de Sobrevida
11.
Sci Total Environ ; 621: 1057-1065, 2018 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-29066203

RESUMO

This experiment was conducted to investigate the remediation effects of bio-conditioners vermicompost (VC) and biochar (BC) on cadmium contaminated soil under the threat of acid rain, individually and associatively. With the application of soil conditioners, the percentages of HOAc-extractable Cd decreased 5.2-6.8%, 9.0-13.5% and 7.9-12.1% in the groups amended with VC, BC and VC combined BC, respectively. When the pH of rain decreased from 7.0 to 4.0, the activity of acid phosphatase decreased 2.0%, 12.3%, 3.2%, 14.8% in VC, BC, VC combined BC and control groups, individually. This study affirmed that with the application of soil conditioners, the threat of heavy metal along with bioavailability of Cd was depressed, and the properties of soil biochemical indictors were enhanced. Oppositely, the bioavailability of Cd was promoted, and soil microbial viability as well as nutrient contents was inhibited with the spraying of acid rain. The findings indicated that acid deposition played a restrain effect on soil remediation process. Meanwhile, soil conditioners showed potentials to improve soil fertilities and alleviate the stress of acid rain.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...